ONO-8025 Phase II Study
Phase 2
- Conditions
- COPD
- Registration Number
- JPRN-jRCT2080221718
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
1.Patients with GOLD stage II or III COPD
Exclusion Criteria
1.Presence or history of bronchial asthma, or presence of lung cancer, bronchiectasis, diffuse panbronchiolitis, sinoatrial syndrome, interstitial pneumonia, tuberculosis, or sequelae of tuberculosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1
- Secondary Outcome Measures
Name Time Method AUC24h of FEV1